Accounts from across the political spectrum describe the operation as a promising clinical milestone: AI gave surgeons an additional real-time view of hazardous anatomy, while the medical team remained responsible for every decision.

For Rhys Hibbert, the stakes were unusually immediate. An 11mm pituitary tumour was threatening his eyesight; for the London clinicians, the challenge was to remove it in an area crowded with nerves and blood vessels without causing lasting harm.

Surgeons at University College London Hospitals’ National Hospital for Neurology and Neurosurgery used the system during Hibbert’s operation in May, after it had previously been confined to research use. Both reports characterise the procedure as the first live AI-assisted brain-tumour removal of its kind, with the software analysing the surgical camera feed and colour-coding structures around the tumour.¹

The emphasis in both accounts is on assistance rather than automation. The technology was trained on hundreds of surgical videos and was designed to recognise anatomy, instruments and tissue interactions in real time. Dr Sophia Bano, the technical lead, said it could expose the system to surgical examples that “would take a surgeon many years to encounter,” while supporting clinicians during delicate work.¹

The account of the operation also stresses why that added visual guidance mattered: officials said an error of as little as a millimetre could have grave consequences. Hani Marcus, the consultant neurosurgeon who performed the procedure, described the trial as “an important first step globally” and said the UK-developed AI could help reduce risk in such surgeries.²

Hibbert’s outcome supplies the human measure of the claims. After surgery, he said, “When I came round, I could see everything in the room clearly,” and he later returned to work as a customer service manager.¹ The reports differ mainly in emphasis—one foregrounds the technological landmark, the other the patient’s participation in research—but agree that the result rested on an AI tool working alongside, not instead of, surgeons.